William Werbel MD PhD
@HIV_TID
Followers
484
Following
2K
Media
40
Statuses
480
Transplant/Oncology Infectious Diseases @JHMed_ID; Epi/Quant @Hopkins_TRC. Advancing intersection of HIV & transplantation, studying đź’‰ vs viruses. Views=me
Joined January 2020
The Emerging Pathogens of Concern (EPOC) research study (IRB0038184; Principal Investigator Dr. William Werbel) is live, studying infections & vaccines in immunocompromised persons & close contacts. Visit or email emergingpathogens@jh.edu for more info!.
0
3
12
RT @GileadSciences: #GileadNews: The FDA has approved our injectable HIV-1 prevention medication, making it the first and only twice-yearly….
0
87
0
RT @KottonNelson: Very proud of the 17 dismissed ACIP members for writing this together – Advisory Committee on Immunization Practices at….
jamanetwork.com
In this Viewpoint, former members of the Advisory Committee on Immunization Practices (ACIP) caution that the sudden change in the ACIP may reverse the achievements of US immunization policy,...
0
19
0
RT @andrewpekosz: A bill to dissolve NIAID has been introduced in Congress. Start contacting your US legislators now!. .
congress.gov
Summary of H.R.1497 - 119th Congress (2025-2026): NIH Reform Act
0
56
0
RT @JAMA_current: Sanjat Kanjilal of Harvard Medical School joins JAMA Associate Editor Yulin Hswen to discuss the use of machine learning….
edhub.ama-assn.org
A recent study in JAMA Network Open evaluates the use of machine learning algorithms to assess the management of urinary tract infection (UTI). Author Sanjat Kanjilal, MD, MPH, professor in the...
0
4
0
RT @Farzad_MD: 1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Offic….
0
5K
0
Ringing in 2025 with our work evaluating antibody response to RSV vaccines in immunocompromised persons in @JAMA_current (Editor's choice!). A preliminary product of our ongoing EPOC study (.@Hopkins_TRC @AndrewKaraba @Dorry_Segev.
jamanetwork.com
This prospective study investigates antibody response following respiratory syncytial virus vaccination in immunocompromised individuals.
2
0
6
RT @IDSAInfo: New #LetsTalkID episode out now!. Medical editors of the Real-Time Learning Network (@MatiH_ID, @Payal_Patel, @mariasundaram,….
0
5
0
RT @HopkinsMedNews: Study in @NEJM ( led by @HopkinsMedicine provides strong evidence that #HIV-to-HIV transplants….
hopkinsmedicine.org
0
10
0
RT @MichaelGIsonMD: 🚨 CRITICAL READ 🚨. If you do research in Transplant ID, this paper is a MUST read. From @CMDurandMD and the @Hopkins_T….
onlinelibrary.wiley.com
A successful multidisciplinary research center depends on the quality of the science being conducted and the quality of the center's design, culture, infrastructure, and institutional support. In...
0
17
0
🫡.
Coming to the end of an era after almost 4 years with the editorial board of the COVID-19 Real Time Learning Network @RealTimeCOVID19. As the grant comes to an end we came together to record a podcast for this incredible resource we built: dropping soon!
0
0
1
Thank you for featuring this insightful work led by @MayanTeles @ Janetta Brundage.
➡️ 29.8% of patients with systemic autoimmune diseases reported long #COVID 12 or more weeks after infection, new data shows #medtwitter #rheumtwitter. Healio has the rundown, with input from co-author @HIV_TID 👇.
1
2
3
RT @AASLDFoundation: Introducing the 2024 Pilot Research Awardees! 🤩 Huge congrats to Patricia Bloom, MD. Learn more about AASLD Foundatio….
0
5
0
Definitionally re: reinfections, 1st had to have occurred earlier (in less immune state), ? complicated by persistent or later "exacerbatable" sequelae. Also ? link between heavier immunosuppression and reinfection risk post vaccination. Regardless, data support đź’‰ in this group.
0
0
0
≥1 symptom reported by 30%, widely varying phenotypes (subgroup with symptoms in all 5 domains). This was following mild infections, majority post vaccination in Omicron era. Pre-infxn vaccination appeared protective! Whereas reinfections might be risk for #PASC.
1
0
0
Great work @MayanTeles @janettabrundage @TeresaChiangMD in assessing post-acute COVID aka #longcovid prevalence, syndromes, and risk factors in persons with autoimmune/rheumatic conditions leveraging our national prospective cohort. @JHMed_ID @Hopkins_TRC.
pubmed.ncbi.nlm.nih.gov
In a large, real-world cohort, 29.8% of persons with systemic autoimmune disease reported PASC, often affecting QOL. Preceding vaccination may reduce PASC, whereas multiple infections may increase...
1
0
0
RT @CIDJournal: Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transpla….
academic.oup.com
Abstract. Durability of variant neutralization in solid organ transplant recipients following Omicron-containing boosters is unknown. We report wane in XBB
0
3
0
Congrats @Hopkins_TRC crew, thank you participants! XBB neutralization wanes 3 mo post bivalent đź’‰in #transplant recipients, improves w/ 2nd đź’‰, varies greatly by hx infxn. Many infxn-naive recipients did not mount XBB neut post 2 đź’‰. Important to optimize and tailorđź’‰ schedule.
Study in @CIDJournal ( by @HopkinsMedicine @JHMed_ID finds booster doses of #BivalentVaccines given every 3-6 months helps maintain a person’s ability to neutralize multiple #SARSCoV2 strains, incl. XBB.1.5 (. @AndrewKaraba @HIV_TID
0
0
2
RT @AST_IDCOP: 📢Trainee poster! ID fellow Dr. Lucy Li from @JHMed_ID presenting on Time-Varying Impact of Post-Transplant Invasive Fungal I….
0
3
0
RT @TxID_Edu: Wow. @AndrewKaraba giving a plenary session talk at @ATCMeeting @AST_IDCOP . RSV vaccine immunogenicity in SOTr https://t.co/….
0
7
0